ANTI-TAC THERAPY FOR UVEITIS
NCT00001526
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
NIH
Sponsor class
Conditions
Uveitis
Interventions
DRUG:
Daclizumab (Zenapax)
Sponsor
National Eye Institute (NEI)